GB9126677D0
(en)
|
1991-12-16 |
1992-02-12 |
Johnson Matthey Plc |
Improvements in chemical compounds
|
GB9318550D0
(en)
*
|
1993-09-07 |
1993-10-20 |
Nycomed Salutar Inc |
Chelants
|
GB9400411D0
(en)
*
|
1994-01-11 |
1994-03-09 |
Johnson Matthey Plc |
Improvements in chemical compounds
|
US5663161A
(en)
*
|
1995-02-17 |
1997-09-02 |
The Research Foundation Of State University Of New York |
Anti-viral triaza compounds
|
US5612478A
(en)
*
|
1995-03-30 |
1997-03-18 |
Johnson Matthey Plc |
Process for preparing 1,1'-[1,4-phenylenebis-(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane
|
US5606053A
(en)
*
|
1995-05-02 |
1997-02-25 |
Johnson Matthey Plc |
Process for preparing 1,1'-[1,4-phenylenebis-(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane
|
US6506770B1
(en)
|
1996-06-06 |
2003-01-14 |
Anormed, Inc. |
Antiviral compounds
|
GB9511357D0
(en)
*
|
1995-06-06 |
1995-08-02 |
Johnson Matthey Plc |
Improved antiviral compounds
|
US5608061A
(en)
*
|
1995-08-02 |
1997-03-04 |
Johnson Matthey Plc |
Process for preparing 1,4,8,11-tetraazacyclotetradecane
|
US7087648B1
(en)
*
|
1997-10-27 |
2006-08-08 |
The Regents Of The University Of California |
Methods for modulating macrophage proliferation using polyamine analogs
|
US6498155B1
(en)
|
1998-11-17 |
2002-12-24 |
Smithkline Beecham Corporation |
Methods of treating thrombocytopenia
|
US6365583B1
(en)
|
1999-02-02 |
2002-04-02 |
Anormed, Inc. |
Methods to enhance white blood cell count
|
NZ514709A
(en)
*
|
1999-03-24 |
2003-03-28 |
Anormed Inc |
Heterocyclic substituted 1,4-benzene dimethanamine derivatives useful for treating disorders mediated by chemokine receptor binding or associated with an abnormal immune response
|
US6750348B1
(en)
*
|
1999-03-24 |
2004-06-15 |
Anormed, Inc. |
Chemokine receptor binding heterocyclic compounds
|
JP2002543126A
(ja)
*
|
1999-05-03 |
2002-12-17 |
スミスクライン・ビーチャム・コーポレイション |
Cxcr−4受容体アンタゴニスト−トロンボポエチン模倣物
|
CN100335478C
(zh)
|
1999-12-17 |
2007-09-05 |
阿诺麦德股份有限公司 |
结合趋化因子受体的杂环化合物
|
CA2400157A1
(en)
*
|
2000-02-22 |
2001-08-30 |
Ram W. Sabnis |
Organic polymeric antireflective coatings deposited by chemical vapor deposition
|
RU2289581C2
(ru)
*
|
2000-09-15 |
2006-12-20 |
Анормед, Инк. |
Гетероциклические соединения, содержащая их фармацевтическая композиция и их применение
|
NZ524421A
(en)
|
2000-09-15 |
2005-02-25 |
Anormed Inc |
Chemokine receptor binding heterocyclic compounds
|
IL154229A0
(en)
|
2000-09-15 |
2003-07-31 |
Anormed Inc |
Chemokine receptor binding heterocyclic compounds
|
US6489472B2
(en)
|
2000-09-29 |
2002-12-03 |
Anormed, Inc. |
Process for preparation of N-1 protected N ring nitrogen containing cyclic polyamines and products thereof
|
DE10117206A1
(de)
*
|
2001-04-06 |
2002-10-10 |
Bayer Ag |
Verfahren zur Herstellung von halogensubstituierten Dibenzylalkoholen, diese halogensubstituierten Dibenzylalkohole sowie deren Verwendung
|
US7169750B2
(en)
*
|
2001-07-31 |
2007-01-30 |
Anormed, Inc. |
Methods to mobilize progenitor/stem cells
|
EP1411918B1
(de)
*
|
2001-07-31 |
2011-12-28 |
Genzyme Global S.à.r.l. |
Verfahren zur mobilisierung von vorläufer/stammzellen
|
RU2308451C2
(ru)
|
2001-09-12 |
2007-10-20 |
Анормед, Инк. |
Способы получения рацемического аминозамещенного 5,6,7,8-тетрагидрохинолина или рацемического аминозамещенного 5,6,7,8-тетрагидроизохинолина, способы их разделения и рацемизации, способ получения кетозамещенного 5,6,7,8-тетрагидрохинолина или кетозамещенного 5,6,7,8-тетрагидроизохинолина, способ получения энантиомера конденсированного бициклического кольца, замещенного первичным амином, производные 5,6,7,8-тетрагидрохинолина
|
US7354932B2
(en)
*
|
2001-12-21 |
2008-04-08 |
Anormed, Inc. |
Chemokine receptor binding heterocyclic compounds with enhanced efficacy
|
MXPA04006136A
(es)
|
2001-12-21 |
2004-11-01 |
Anormed Inc |
Compuestos heterociclicos que se unen a receptor de quimiocina con eficacia incrementada.
|
CA2472711C
(en)
|
2002-01-18 |
2012-03-20 |
Yamanouchi Pharmaceutical Co., Ltd. |
2-acylaminothiazole derivative or salt thereof
|
EP1613613B1
(de)
*
|
2003-04-11 |
2021-06-02 |
Genzyme Corporation |
Cxcr4-chemokinrezeptor-bindende verbindungen
|
US7501518B2
(en)
*
|
2003-04-22 |
2009-03-10 |
Genzyme Corporation |
Methods of making 2,6-diaryl piperidine derivatives
|
MXPA05011353A
(es)
|
2003-04-22 |
2005-11-28 |
Anormed Inc |
Compuestos heterociclicos que se unen al receptor de quimiocina con eficacia mejorada.
|
CA2548393A1
(en)
*
|
2003-12-11 |
2005-06-30 |
Anormed Inc. |
Chemokine receptor binding compounds
|
US7498346B2
(en)
*
|
2003-12-11 |
2009-03-03 |
Genzyme Corporation |
Chemokine receptor binding compounds
|
ES2614508T3
(es)
*
|
2004-03-15 |
2017-05-31 |
Genzyme Corporation |
Proceso para la síntesis de un antagonista de CXCR4
|
ATE492523T1
(de)
*
|
2004-08-05 |
2011-01-15 |
Sumitomo Chemical Co |
Verfahren zur herstellung von halogensubstituiertem benzoldimethanol
|
WO2006020891A2
(en)
*
|
2004-08-13 |
2006-02-23 |
Anormed Inc. |
Chemokine combinations to mobilize progenitor/stem cells
|
TW200619206A
(en)
*
|
2004-09-29 |
2006-06-16 |
Anormed Inc |
Chemokine-binding heterocyclic compound salts, and methods of use thereof
|
US9789171B2
(en)
*
|
2004-11-05 |
2017-10-17 |
The General Hospital Corporation |
Anti-fugetactic agents for the treatment of ovarian cancer
|
WO2006138350A2
(en)
*
|
2005-06-15 |
2006-12-28 |
Anormed Inc. |
Chemokine receptor binding compounds
|
CA2619881A1
(en)
*
|
2005-08-16 |
2007-02-22 |
Genzyme Corporation |
Chemokine receptor binding compounds
|
WO2007022523A2
(en)
|
2005-08-19 |
2007-02-22 |
Genzyme Corporation |
Methods to enhance chemotherapy
|
KR20080074166A
(ko)
*
|
2005-11-08 |
2008-08-12 |
아스테라스 세이야쿠 가부시키가이샤 |
혈소판감소증을 치료하는 조성물 및 방법
|
EP1978008B1
(de)
|
2006-01-24 |
2011-07-20 |
Sumitomo Chemical Company, Limited |
Verfahren zur herstellung von halogensubstituiertem benzoldimethanol
|
JP2009527552A
(ja)
*
|
2006-02-24 |
2009-07-30 |
ジェンザイム・コーポレーション |
血流の増加および組織再生の促進またはそのいずれかのための方法
|
AR063470A1
(es)
*
|
2006-08-02 |
2009-01-28 |
Genzyme Corp |
Terapia combinada
|
MX2009001445A
(es)
*
|
2006-08-07 |
2009-02-18 |
Genzyme Corp |
Terapia de combinacion.
|
ES2452032T3
(es)
*
|
2006-08-08 |
2014-03-31 |
Akarx, Inc. |
Composiciones y métodos para aumentar los niveles de plaquetas de la sangre en humanos
|
WO2008109076A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Oxigene, Inc. |
Methods for enhancing the efficacy of vascular disrupting agents
|
CA2688504A1
(en)
|
2007-06-18 |
2008-12-24 |
Children's Hospital & Research Center At Oakland |
Method of isolating stem and progenitor cells from placenta
|
US9822364B2
(en)
|
2008-03-11 |
2017-11-21 |
Yale University |
Compositions and methods for controlled delivery of inhibitory ribonucleic acids
|
US9241898B2
(en)
|
2008-03-11 |
2016-01-26 |
Yale University |
Compositions and methods for controlled delivery of inhibitory ribonucleic acids
|
EP2149567A1
(de)
*
|
2008-07-18 |
2010-02-03 |
Bayer Schering Pharma Aktiengesellschaft |
Zyklische Polyamine die an Phosphatidylserin binden
|
US8771677B2
(en)
*
|
2008-12-29 |
2014-07-08 |
Vladimir B Serikov |
Colony-forming unit cell of human chorion and method to obtain and use thereof
|
JP2014513727A
(ja)
|
2011-05-16 |
2014-06-05 |
ジェンザイム・コーポレーション |
Cxcr4拮抗薬の使用
|
US10465042B2
(en)
|
2011-12-02 |
2019-11-05 |
Yale University |
Poly(amine-co-ester) nanoparticles and methods of use thereof
|
WO2013082529A1
(en)
|
2011-12-02 |
2013-06-06 |
Yale University |
Enzymatic synthesis of poly(amine-co-esters) and methods of use thereof for gene delivery
|
US9895451B2
(en)
|
2011-12-02 |
2018-02-20 |
Yale University |
Formulations for targeted release of agents to low pH tissue environments or cellular compartments and methods of use thereof
|
WO2014125499A1
(en)
|
2013-02-13 |
2014-08-21 |
Natco Pharma Limited |
Improved and commercially viable process for the preparation of high pure plerixafor base
|
PT107018A
(pt)
*
|
2013-06-20 |
2014-12-22 |
Inst Superior Técnico |
Síntese e uso de ciclamas com atividade antibacteriana
|
US20160206592A1
(en)
|
2013-08-30 |
2016-07-21 |
Ramot At Tel-Aviv University Ltd. |
Method for treating amyotrophic lateral sclerosis by inhibition of cxcr4/cxcl12 signaling
|
US11918695B2
(en)
|
2014-05-09 |
2024-03-05 |
Yale University |
Topical formulation of hyperbranched polymer-coated particles
|
WO2015172153A1
(en)
|
2014-05-09 |
2015-11-12 |
Yale University |
Topical formulation of hyperbranched polyglycerol-coated particles thereof
|
US10682422B2
(en)
|
2014-11-18 |
2020-06-16 |
Yale University |
Formulations for targeted release of agents under low pH conditions and methods of use thereof
|
WO2016081621A1
(en)
|
2014-11-18 |
2016-05-26 |
Yale University |
Formulations for targeted release of agents under low ph conditions and methods of use thereof
|
EP3050574B1
(de)
|
2015-01-28 |
2019-10-09 |
Universite De Bordeaux |
Verwendung von Plerixafor zur Behandlung und/oder Vorbeugung von akuten Exazerbationen einer chronisch obstruktiver Lungenerkrankung
|
EP3288638A1
(de)
|
2015-04-25 |
2018-03-07 |
The General Hospital Corporation |
Kombinationstherapie und zusammensetzungen aus antifugetaktischem mittel und antikrebsmittel zur behandlung von krebs
|
EP3302710A4
(de)
|
2015-06-03 |
2019-02-20 |
The University of Queensland |
Mobilisierungsmittel und verwendung davon
|
WO2017037639A1
(en)
|
2015-09-02 |
2017-03-09 |
Fresenius Kabi Oncology Ltd. |
A process for the preparation of xylene linked cyclam compounds
|
JP2018531229A
(ja)
|
2015-09-18 |
2018-10-25 |
ザ ジェネラル ホスピタル コーポレーション ドゥーイング ビジネス アズ マサチューセッツ ジェネラル ホスピタル |
癌の治療のための抗fugetactic剤の局所的送達
|
WO2017106328A1
(en)
|
2015-12-14 |
2017-06-22 |
X4 Pharmaceuticals, Inc. |
Methods for treating cancer
|
US11357742B2
(en)
|
2015-12-14 |
2022-06-14 |
X4 Pharmaceuticals, Inc. |
Methods for treating cancer
|
WO2017106630A1
(en)
|
2015-12-18 |
2017-06-22 |
The General Hospital Corporation |
Polyacetal polymers, conjugates, particles and uses thereof
|
US10610527B2
(en)
|
2015-12-22 |
2020-04-07 |
X4 Pharmaceuticals, Inc. |
Methods for treating immunodeficiency disease
|
CA3014795A1
(en)
|
2016-02-16 |
2017-08-24 |
Yale University |
Compositions and methods for treatment of cystic fibrosis
|
US11136597B2
(en)
|
2016-02-16 |
2021-10-05 |
Yale University |
Compositions for enhancing targeted gene editing and methods of use thereof
|
JP2019510785A
(ja)
|
2016-04-08 |
2019-04-18 |
エックス4 ファーマシューティカルズ, インコーポレイテッド |
癌を処置する方法
|
WO2017197128A1
(en)
|
2016-05-11 |
2017-11-16 |
Yale University |
Poly(amine-co-ester) nanoparticles and methods of use thereof
|
CN109562106B
(zh)
|
2016-06-21 |
2023-03-21 |
X4 制药有限公司 |
Cxcr4抑制剂及其用途
|
EP3472129A4
(de)
|
2016-06-21 |
2019-12-04 |
X4 Pharmaceuticals, Inc. |
Cxcr4-inhibitoren und verwendungen davon
|
CA3027495A1
(en)
|
2016-06-21 |
2017-12-28 |
X4 Pharmaceuticals, Inc. |
Cxcr4 inhibitors and uses thereof
|
JP2019534249A
(ja)
|
2016-09-09 |
2019-11-28 |
ザ ジェネラル ホスピタル コーポレイション |
癌の治療のための抗化学忌避剤とのhsp融合タンパク質
|
WO2018049120A1
(en)
|
2016-09-09 |
2018-03-15 |
The General Hospital Corporation |
Ex vivo antigen-presenting cells or activated cd-positive t cells for treatment of cancer
|
US11453706B2
(en)
|
2016-09-09 |
2022-09-27 |
The General Hospital Corporation |
HSP fusion protein with anti-chemorepellant agent for treatment of infectious disease
|
WO2018053270A1
(en)
|
2016-09-16 |
2018-03-22 |
The General Hospital Corporation |
Modified natural killer cells for the treatment of cancer
|
WO2018106738A1
(en)
|
2016-12-05 |
2018-06-14 |
Massachusetts Institute Of Technology |
Brush-arm star polymers, conjugates and particles, and uses thereof
|
JP2020515542A
(ja)
|
2017-03-23 |
2020-05-28 |
ザ ジェネラル ホスピタル コーポレイション |
Cxcr4/cxcr7の遮断およびヒトパピローマウイルス関連疾患の治療
|
WO2018187493A1
(en)
|
2017-04-04 |
2018-10-11 |
Yale University |
Compositions and methods for in utero delivery
|
JP2021503008A
(ja)
|
2017-10-31 |
2021-02-04 |
マジェンタ セラピューティクス インコーポレイテッドMagenta Therapeutics, Inc. |
造血幹細胞および前駆細胞移植療法のための組成物および方法
|
WO2019089826A1
(en)
|
2017-10-31 |
2019-05-09 |
Magenta Therapeutics Inc. |
Compositions and methods for the expansion of hematopoietic stem and progenitor cells
|
JP2021505172A
(ja)
|
2017-12-06 |
2021-02-18 |
マジェンタ セラピューティクス インコーポレイテッドMagenta Therapeutics, Inc. |
造血幹細胞及び前駆細胞を動員させるための投薬レジメン
|
US10058573B1
(en)
|
2017-12-06 |
2018-08-28 |
Magenta Therapeutics, Inc. |
Dosing regimens for the mobilization of hematopoietic stem cells
|
US11260079B2
(en)
|
2017-12-06 |
2022-03-01 |
Magenta Therapeutics, Inc. |
Dosing regimens for the mobilization of hematopoietic stem and progenitor cells
|
US20200338132A1
(en)
|
2018-01-03 |
2020-10-29 |
Magenta Therapeutics Inc. |
Compositions and methods for the expansion of hematopoietic stem and progenitor cells and treatment of inherited metabolic disorders
|
US20210189431A1
(en)
|
2018-08-10 |
2021-06-24 |
Yale University |
Compositions and methods for embryonic gene editing in vitro
|
US10548889B1
(en)
|
2018-08-31 |
2020-02-04 |
X4 Pharmaceuticals, Inc. |
Compositions of CXCR4 inhibitors and methods of preparation and use
|
US11814464B2
(en)
|
2019-04-29 |
2023-11-14 |
Yale University |
Poly(amine-co-ester) polymers and polyplexes with modified end groups and methods of use thereof
|
US20220372474A1
(en)
|
2019-06-21 |
2022-11-24 |
Yale University |
Hydroxymethyl-modified gamma-pna compositions and methods of use thereof
|
US20220243211A1
(en)
|
2019-06-21 |
2022-08-04 |
Yale University |
Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof
|
WO2021022161A1
(en)
|
2019-07-31 |
2021-02-04 |
Yale University |
Compositions and methods for treating sickle cell disease
|
WO2021087406A1
(en)
|
2019-11-01 |
2021-05-06 |
Magenta Therapeutics, Inc. |
Dosing regimens for the mobilization of hematopoietic stem and progentor cells
|
EP4143302A1
(de)
|
2020-04-27 |
2023-03-08 |
Magenta Therapeutics, Inc. |
Verfahren und zusammensetzungen zur transduktion hämatopoetischer stamm- und vorläuferzellen in vivo
|
MX2022016581A
(es)
|
2020-06-19 |
2023-02-01 |
Univ Yale |
Polimeros de poli(amina-co-ester) con grupos de extremo modificado y liberacion pulmonar mejorada.
|
US20220031633A1
(en)
|
2020-07-28 |
2022-02-03 |
Yale University |
Poly(amine-co-ester) polymeric particles for selective pulmonary delivery
|
WO2022197776A1
(en)
|
2021-03-16 |
2022-09-22 |
Magenta Therapeutics, Inc. |
Dosing regimens for hematopoietic stem cell mobilization for stem cell transplants in multiple myeloma patients
|
US20230104658A1
(en)
|
2021-10-01 |
2023-04-06 |
Janssen Pharmaceutica Nv |
Methods of increasing progenitor cell production
|
WO2023108076A1
(en)
|
2021-12-08 |
2023-06-15 |
Yale University |
Surface conjugation to poly(amine-co-ester) nanoparticles for targeting to cells and tissues
|
WO2023159189A1
(en)
|
2022-02-18 |
2023-08-24 |
Yale University |
Branched poly(amine-co-ester) polymers for more efficient nucleic expression
|